Acarbose D-Fructose 1,6,6’,6’’’-Tetra-tert-butyldimethylsilyloxymethyl Ether

• Catalog number
  A123525
• Price
  Please ask
• Size
  1 mg

• Chemical available in other sizes
  Please inquire size and price
• Stock availability
  Pending QC
• Cas number
  This product doesn't have CAS Number
• Chemical s molecular weight
  1102.65
• Chemical s main applications
  Acarbose D-Fructose 1,6,6’,6’’’-Tetra-tert-butyldimethylsilyloxy Methyl Ether is a protected intermediate of Acarbose D-Fructose (A123515), a derivative of the antibiotic, Acarbose (A123500) (1,2).
• Chemical s category
  Impurities, Oligosaccharides
• Other name
  (7S,8R,9R)-8-(((2R,3R,4R,5S,6R)-6-(((tert-Butyldimethylsilyl)oxy)methyl)-5-(((2R,3R,4S,5S,6R)-5-(((1S,4S,5S,6S)-3-(((tert-butyldimethylsilyl)oxy)methyl)-4,5,6-trihydroxycyclohex-2-en-1-yl)amino)-3,4-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-7,9-dihydroxy-2,2,3,3,12,12,13,13-octamethyl-4,11-dioxa-3,12-disilatetradecan-6-one
• Chemical s formula
  C49H99NO18Si4
• Physical properties
  Off-White Solid
• Melting temperature
  No Data Available
• Boiling temperature
  No Data Available
• Chemical s soluble in
  Methanol
• Stability conditions
  No Data Available
• Storage
  No Data Available
• Chemical s specifications

• Gene target
  Acarbose   D-Fructose   6’’’   Tetra-tert-butyldimethylsilyloxymethyl   Ether  
• Short name
  Acarbose D-Fructose 1 6 6’,6’’’-Tetra-tert-butyldimethylsilyloxymethyl Ether
• Alternative name
  Acarbose D-Fructose 1,6,6’,6’’’-Tetra-telomerase reverse transcriptase-butyldimethylsilyloxymethyl Ether
• Alternative to gene target
  telomerase reverse transcriptase, CMM9 and DKCA2 and DKCB4 and EST2 and hEST2 and hTRT and PFBMFT1 and TCS1 and TP2 and TRT, TERT and IDBG-10998 and ENSG00000164362 and 7015, telomeric RNA binding, nuclei, Tert and IDBG-165912 and ENSMUSG00000021611 and 21752, BT.60929 and IDBG-632169 and ENSBTAG00000012567 and 518884

MeSH Data

• Name
  Cloning, Molecular
• Concept
  Scope note: The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
• Tree numbers
  • E05.393.220
• Qualifiers
  drug effects, methods, radiation effects

Similar products